Planned Concomitant Left and Right Ventricular Assist Device Insertion to Avoid Long-term Biventricular Mechanical Support: Bridge to Right Ventricular Recovery
DOI:
https://doi.org/10.1532/hsf.2035Abstract
Introduction: The planned use of a temporary right ventricular assist device (RVAD) at the time of left ventricular assist device (LVAD) implantation may prevent the need for a permanent biventricular assist device (BiVAD). Herein we describe our RVAD weaning protocol that was effectively employed in
4 patients to prevent the need for permanent BiVAD.
Methods: Four patients in refractory cardiogenic shock underwent planned RVAD insertion during LVAD implantation due to severely depressed right ventricular function with dilation preoperatively. A standardized RVAD weaning protocol was employed in these 4 patients in preparation for decannulation.
Results: Temporary RVADs were successfully placed in all 4 patients at the time of LVAD implantation. All patients survived to RVAD decannulation and discharge and were alive at the time of most recent follow-up (range, 528-742 days post–RVAD decannulation).
Conclusion: Planned implantation of a temporary RVAD in high risk patients may avoid the need for biventricular mechanical support in the future.
References
Anderson B, Goldstein J, Milano C, et al. 2015. Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device. J Heart Lung Transplant 34:1549-60.
Kang G, Ha R, Banerjee D. 2016. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant 35:67-73.
Kirklin JK, Naftel DC, Kormos RL, et al. 2013. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant 32:141-56.
Levin AP, Jaramillo N, Garan AR, et al. 2016. Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure. J Thorac Cardiovasc Surg 151:530-535.e2.
Ravichandran AK, Baran DA, Stelling K, Cowger JA, Salerno CT. 2018. Outcomes with the Tandem Protek Duo dual-lumen percutaneous right ventricular assist device. ASAIO J 64:570-2.
Rose EA, Gelijns AC, Moskowitz AJ, et al. 2001. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345:1435-43.
Takeda K, Naka Y, Yang JA, et al. 2014. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant 33:141-8.
Yancy CW, Jessup M, Bozkurt B, et al. 2013. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147-239.
